# Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer

> **NCT00257426** · PHASE2 · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 31 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** octreotide acetate

## Key facts

- **NCT ID:** NCT00257426
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-02
- **Final completion:** 2009-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2012-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00257426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00257426, "Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00257426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*